Annual report [Section 13 and 15(d), not S-K Item 405]

Promissory Notes (Details Narrative)

v3.26.1
Promissory Notes (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 9 Months Ended
Dec. 15, 2025
Jul. 11, 2025
May 12, 2025
Feb. 21, 2025
Apr. 29, 2024
Sep. 30, 2025
Sep. 30, 2025
Dec. 31, 2025
Short-Term Debt [Line Items]                
Effective interest rate               28.40%
Derivative liability               $ 171
Fee amount             $ 595  
Stock issued during the period, shares     61,111   19,444      
Purchase Agreement                
Short-Term Debt [Line Items]                
Principal amount       $ 3,300        
July Purchase Agreement                
Short-Term Debt [Line Items]                
Principal amount   $ 2,755            
DNA Holdings Ventures Inc [Member]                
Short-Term Debt [Line Items]                
Convertble notes issued $ 1,200              
Interest rate percentage 10.00%              
Interest rate percentage, default 20.00%              
Initial conversion price of convertible note $ 5.50              
Covertible note terms, description At any time after (i) the termination of the Asset Purchase Agreement or (ii) during the continuance of any event of default under the DNA Note, the conversion price will equal the “Alternate Conversion Price,” which is defined as 80% of the closing price of the Company’s common stock on the Company’s principal trading market on the date of conversion (subject to the same adjustment provisions described above). In addition, if at any time the Depository Trust Company imposes a “chill” on the Company’s shares, the holder may convert the DNA Note at the Alternate Conversion Price while such “chill” is in effect.              
Effective interest rate               10.00%
Convertible note payment terms the Company is required to redeem the outstanding principal amount of the DNA Note for cash at a price equal to 110% of the then outstanding principal amount, plus accrued but unpaid interest and any other amounts then due under the DNA Note (the “Redemption Amount”), at the closing of such transaction. Notwithstanding the foregoing, the transactions contemplated by the Asset Purchase Agreement do not constitute a Change of Control Transaction under the DNA Note. In lieu of receiving the Redemption Amount, and subject to any required stockholder approval under the rules of the Company’s principal trading market, the holder may elect to convert the DNA Note, in whole or in part, upon a Change of Control Transaction at a price per share equal to the lower of (i) the closing price of common stock on the original issue date of the DNA Note and (ii) the closing price of common stock on the date of consummation of such Change of Control Transaction.              
DNA Holdings Ventures Inc [Member] | Minimum [Member]                
Short-Term Debt [Line Items]                
Initial conversion price of convertible note $ 1.10              
The February Note                
Short-Term Debt [Line Items]                
Interest rate percentage       22.00%        
Effective interest rate               28.40%
Original issue discount       $ 270        
Payments for legal fees       30        
Principal amount       3,000        
Issuance costs       $ 210        
Interest rate       9.00%        
Outstanding percentage       110.00%        
Debt instrument redemption amount       $ 330        
Outstanding percentage       1.00%        
The February Note | Major Trigger Event                
Short-Term Debt [Line Items]                
Outstanding percentage       15.00%        
The February Note | Minor Trigger Event                
Short-Term Debt [Line Items]                
Outstanding percentage       5.00%        
The February Note | Exchange Agreement                
Short-Term Debt [Line Items]                
Stock issued during the period, shares           30,188    
Principal balance           $ 375 $ 375  
Debt discount and debt issuance costs           $ 58    
July Note                
Short-Term Debt [Line Items]                
Interest rate percentage   22.00%            
Effective interest rate               23.00%
Original issue discount   $ 225            
Payments for legal fees   30            
Debt instrument redemption amount   $ 275            
Outstanding percentage   1.00%            
Purchase price   $ 2,500            
Issuance cost   $ 210            
Accrues interest rate   9.00%            
Debt instrument description   The Company may prepay all or any portion of the outstanding balance of the July Note. If the Company elects to prepay the July Note in part, it will be required to pay to the Lender an amount in cash equal to 110% of the portion of the outstanding balance the Company elects to prepay. In addition, any time the Company receives any money in connection with any fundraising or financing transaction (including, but not limited to, any warrant exercises, “at the market” financing, equity line of credit or debt financing), it must immediately make a mandatory prepayment to the Lender in an amount equal to the lesser of (a) 33% of the amount raised in such transaction, and (b) the total outstanding balance due under the July Note as of the closing date of such financing, payable within two trading days of receiving such amount.            
July Note | Minimum [Member]                
Short-Term Debt [Line Items]                
Percent increase in balance for each Major Trigger Event   5.00%            
July Note | Maximum [Member]                
Short-Term Debt [Line Items]                
Percent increase in balance for each Major Trigger Event   15.00%